These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19151923)

  • 21. Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach.
    Subba Rao G; Vijayakrishnan R; Kumar M
    Chem Biol Drug Des; 2008 Nov; 72(5):444-9. PubMed ID: 19012578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A triclosan-resistance protein from the soil metagenome is a novel enoyl-acyl carrier protein reductase: Structure-guided functional analysis.
    Kim SH; Khan R; Choi K; Lee SW; Rhee S
    FEBS J; 2020 Nov; 287(21):4710-4728. PubMed ID: 32112503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enoyl acyl carrier protein reductase inhibitors: an updated patent review (2011 - 2015).
    Zitko J; Doležal M
    Expert Opin Ther Pat; 2016 Sep; 26(9):1079-94. PubMed ID: 27399249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis and mechanism of enoyl reductase inhibition by triclosan.
    Stewart MJ; Parikh S; Xiao G; Tonge PJ; Kisker C
    J Mol Biol; 1999 Jul; 290(4):859-65. PubMed ID: 10398587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystallographic insights into the structure-activity relationships of diazaborine enoyl-ACP reductase inhibitors.
    Jordan CA; Sandoval BA; Serobyan MV; Gilling DH; Groziak MP; Xu HH; Vey JL
    Acta Crystallogr F Struct Biol Commun; 2015 Dec; 71(Pt 12):1521-30. PubMed ID: 26625295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition.
    Maity K; Bhargav SP; Sankaran B; Surolia N; Surolia A; Suguna K
    IUBMB Life; 2010 Jun; 62(6):467-76. PubMed ID: 20503440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enoyl acyl carrier protein reductase inhibitors: a patent review (2006 - 2010).
    Lu X; Huang K; You Q
    Expert Opin Ther Pat; 2011 Jul; 21(7):1007-22. PubMed ID: 21651455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enoyl reductases as targets for the development of anti-tubercular and anti-malarial agents.
    Oliveira JS; Vasconcelos IB; Moreira IS; Santos DS; Basso LA
    Curr Drug Targets; 2007 Mar; 8(3):399-411. PubMed ID: 17348833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structures of Enoyl-ACP reductases I (FabI) and III (FabL) from B. subtilis.
    Kim KH; Ha BH; Kim SJ; Hong SK; Hwang KY; Kim EE
    J Mol Biol; 2011 Feb; 406(3):403-15. PubMed ID: 21185310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structures and kinetic properties of enoyl-acyl carrier protein reductase I from Candidatus Liberibacter asiaticus.
    Jiang L; Gao Z; Li Y; Wang S; Dong Y
    Protein Sci; 2014 Apr; 23(4):366-77. PubMed ID: 24407918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triclosan Resistance in a Bacterial Fish Pathogen, Aeromonas salmonicida subsp. salmonicida, is Mediated by an Enoyl Reductase, FabV.
    Khan R; Lee MH; Joo HJ; Jung YH; Ahmad S; Choi JH; Lee SW
    J Microbiol Biotechnol; 2015 Apr; 25(4):511-20. PubMed ID: 25370725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of the structure-activity relationship for diazaborine inhibition of Escherichia coli enoyl-ACP reductase.
    Levy CW; Baldock C; Wallace AJ; Sedelnikova S; Viner RC; Clough JM; Stuitje AR; Slabas AR; Rice DW; Rafferty JB
    J Mol Biol; 2001 May; 309(1):171-80. PubMed ID: 11491286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of substrate binding loop mutations on the structure, kinetics, and inhibition of enoyl acyl carrier protein reductase from Plasmodium falciparum.
    Maity K; Banerjee T; Prabakaran N; Surolia N; Surolia A; Suguna K
    IUBMB Life; 2011 Jan; 63(1):30-41. PubMed ID: 21280175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pathogenic fungi diphenyl ether phytotoxin targets plant enoyl (acyl carrier protein) reductase.
    Dayan FE; Ferreira D; Wang YH; Khan IA; McInroy JA; Pan Z
    Plant Physiol; 2008 Jul; 147(3):1062-71. PubMed ID: 18467464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Efficient and Economical Assay to Screen for Triclosan Binding to FabI.
    Demissie RD; Kabre P; Tuntland ML; Fung LW
    J Biomol Screen; 2016 Apr; 21(4):391-8. PubMed ID: 26538431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis.
    Sharma SK; Kumar G; Kapoor M; Surolia A
    Biochem Biophys Res Commun; 2008 Mar; 368(1):12-7. PubMed ID: 17996734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.
    Tallorin LC; Durrant JD; Nguyen QG; McCammon JA; Burkart MD
    Bioorg Med Chem; 2014 Nov; 22(21):6053-6061. PubMed ID: 25284249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational optimization of drug-target residence time: insights from inhibitor binding to the Staphylococcus aureus FabI enzyme-product complex.
    Chang A; Schiebel J; Yu W; Bommineni GR; Pan P; Baxter MV; Khanna A; Sotriffer CA; Kisker C; Tonge PJ
    Biochemistry; 2013 Jun; 52(24):4217-28. PubMed ID: 23697754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of the Francisella tularensis enoyl-acyl carrier protein reductase (FabI) in complex with NAD(+) and triclosan.
    Mehboob S; Truong K; Santarsiero BD; Johnson ME
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Nov; 66(Pt 11):1436-40. PubMed ID: 21045289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.
    Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F
    Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.